[Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance]

Guo-Qi Song1, Ling Gu1, Bang-Shun He1

  • 1Department of Internal Medicine, Southeast University Medical Shool, Nanjiang 210009, Jiangsu Province, China.

Insights

MicroRNA-21 (miR-21) is upregulated in diffuse large B-cell lymphoma (DLBCL) and drives cancer cell proliferation and invasion. Inhibiting miR-21 suppressed DLBCL growth and increased apoptosis, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA-21 (miR-21) is implicated in tumorigenesis by regulating gene expression.
  • The specific role of miR-21 in diffuse large B-cell lymphoma (DLBCL) and its impact on cellular phenotype remain largely uncharacterized.

Purpose of the Study:

  • To investigate the expression levels of miR-21 in DLBCL cell lines.
  • To elucidate the role of miR-21 in regulating the biological behavior of DLBCL cells.
  • To explore the potential therapeutic applications of targeting miR-21 in DLBCL.

Main Methods:

  • Real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR) to measure miR-21 expression.
  • Transfection with anti-miR-21 to achieve miR-21 knockdown in DLBCL cell lines.
  • Luciferase reporter assay, qRT-PCR, and Western blot to assess PDCD4 and PTEN expression.

Main Results:

  • miR-21 expression was significantly higher in activated B-cell-like DLBCL cells compared to germinal centre-like DLBCL cells.
  • Inhibition of miR-21 led to decreased proliferation and invasion, and increased apoptosis in DLBCL cells.
  • Knockdown of miR-21 resulted in elevated protein levels of PDCD4 and PTEN, but not their mRNA levels.

Conclusions:

  • miR-21 plays a significant role in regulating proliferation, invasion, and apoptosis in DLBCL.
  • Targeting miR-21 demonstrates potential as a therapeutic strategy for DLBCL treatment.